Dynamk Capital is a New York-based venture capital firm founded in 2015–2017 by general partners Daniella Kranjac and Mario M. See contact routes.
Dynamk Capital is a New York-based venture capital firm founded in 2015–2017 by general partners Daniella Kranjac and Mario M. Kranjac that specializes in early-stage life science industrials. The firm’s investment thesis targets Seed through Series B companies developing tools, technologies, and services critical to the discovery, development, and manufacturing of biotherapeutics, with a focus on biotechnology, pharmaceuticals, and medical devices. Typical check sizes range from $500,000 to $7 million, and the firm invests across the life sciences sector without publicly disclosing whether it leads or follows rounds. Notable portfolio companies include Alpenglow Biosciences, RoosterBio, Envisagenics, Lucid Scientific, CellFE Biotech, and Vectron Biosolutions. Dynamk distinguishes itself by concentrating exclusively on Life Science Industrials rather than therapeutics, providing portfolio companies with specialized industry expertise in gene-editing, cell therapy, and analytical testing. The firm does not appear to have published public writing or a distinctive point of view beyond its stated mission to accelerate innovation in life-saving therapi
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Dynamk Capital · Full investor directory · Investor access · Company funding database